Literature DB >> 26919226

The effect of antihypertensive treatment on the incidence of stroke and cognitive decline in the elderly: a meta-analysis.

Christine Parsons1, Mohammad Hassan Murad2, Stuart Andersen1, Farouk Mookadam3, Helene Labonte1.   

Abstract

AIM: To evaluate the effectiveness of antihypertensives in reducing neurocognitive outcomes in elderly patients. PATIENTS &
METHODS: We conducted a systematic literature search of randomized trials in which hypertensive patients with a mean age ≥65 years received antihypertensive or control treatment. Outcomes were stroke, transient ischemic attack, cognitive decline and dementia. We included 14 trials for meta-analysis.
RESULTS: Compared to placebo, antihypertensive treatment reduced the risk of stroke (RR: 0.67 [95% CI: 0.57-0.79]). Reduced risk was significant for transient ischemic attack, fatal stroke, nonfatal stroke and total stroke. There were insufficient data to compare individual agents.
CONCLUSION: Antihypertensive treatment is associated with a significant reduction in stroke in elderly individuals. Reductions in dementia and cognitive decline were not significant; however, there was short follow-up. Comparative effectiveness evidence is limited.

Entities:  

Keywords:  aged; cognition; dementia; hypertension; stroke

Mesh:

Substances:

Year:  2016        PMID: 26919226     DOI: 10.2217/fca.15.90

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  9 in total

Review 1.  Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

Authors:  Romain Barus; Johana Béné; Julie Deguil; Sophie Gautier; Régis Bordet
Journal:  Br J Pharmacol       Date:  2019-03-31       Impact factor: 8.739

Review 2.  Pharmacotherapy for hypertension in adults aged 18 to 59 years.

Authors:  Vijaya M Musini; Francois Gueyffier; Lorri Puil; Douglas M Salzwedel; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2017-08-16

3.  Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.

Authors:  Emma L Cunningham; Stephen A Todd; Peter Passmore; Roger Bullock; Bernadette McGuinness
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

4.  Pharmacotherapy for hypertension in adults 60 years or older.

Authors:  Vijaya M Musini; Aaron M Tejani; Ken Bassett; Lorri Puil; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

Review 5.  First-line drugs for hypertension.

Authors:  James M Wright; Vijaya M Musini; Rupam Gill
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

6.  Predictors of Olfactory Decline in Aging: A Longitudinal Population-Based Study.

Authors:  Ingrid Ekström; Maria Larsson; Debora Rizzuto; Johan Fastbom; Lars Bäckman; Erika J Laukka
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-11-13       Impact factor: 6.053

Review 7.  The Association Between Hypertension and Cognitive Impairment, and the Role of Antihypertensive Medications: A Literature Review.

Authors:  Nupur Mishra; Devyani Mohan; Sehrish Fuad; Deepak M Basavanagowda; Zaid A Alrashid; Arveen Kaur; Bindu Rathod; Sadia Nosher; Stacey E Heindl
Journal:  Cureus       Date:  2020-12-11

8.  Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis.

Authors:  Chi-Jung Huang; Chern-En Chiang; Bryan Williams; Kazuomi Kario; Shih-Hsien Sung; Chen-Huan Chen; Tzung-Dau Wang; Hao-Min Cheng
Journal:  Am J Hypertens       Date:  2019-01-15       Impact factor: 2.689

9.  Development and validation of a 2-year new-onset stroke risk prediction model for people over age 45 in China.

Authors:  Qiang Yao; Jing Zhang; Ke Yan; Qianwen Zheng; Yawen Li; Lu Zhang; Chenyao Wu; Yanling Yang; Muke Zhou; Cairong Zhu
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.